About this file

This document outlines a solicitation for a federal contract to acquire medical countermeasures for pandemic influenza and emerging diseases. The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response is seeking firm-fixed prices for various contract line items to support development and production of influenza vaccines and adjuvants. Deliverables include master seed stocks, research vaccine lots, investigational and commercial bulk vaccine lots, adjuvant bulk product, formulation and filling services, storage and stability testing, potency reagents and standards, analytical testing, non-clinical and clinical studies, disposal services, and data reporting over a potential five-year period of performance consisting of a 36-month base period and two 12-month option periods. Responses are due by the date specified in the solicitation, which is available on beta.SAM.gov under solicitation number 75A50121R00013. Awards will be fixed-price contracts.

View the file

Other files

Show all 11

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

August 29, 2021

Effective Immediately, all correspondence relating to RFP # 75A50121R00013 should be emailed to BARDA-FLU-ACQUISITIONS@hhs.gov.

A specific email account was created to ensure all offerors correspondence relating to the requirement is received by the BARDA Contracting.

Feel free to send a test email prior to the proposal submission date to ensure the email account, BARDA-FLU-ACQUISITIONS@hhs.gov, receives your emails.

Deitra Williams mailto:BARDA-FLU-ACQUISITIONS@hhs.gov mailto:BARDA-FLU-ACQUISITIONS@hhs.gov

File details come from the government source that posted it. Updated .